By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Nutriband Inc.

Nutriband Inc. (NTRBW)

NASDAQ Currency in USD
$1.80
-$0.16
-8.16%
Last Update: 12 Sept 2025, 16:23
$20.09M
Market Cap
-2.98
P/E Ratio (TTM)
Forward Dividend Yield
$0.75 - $5.25
52 Week Range

NTRBW Stock Price Chart

Explore Nutriband Inc. interactive price chart. Choose custom timeframes to analyze NTRBW price movements and trends.

NTRBW Company Profile

Discover essential business fundamentals and corporate details for Nutriband Inc. (NTRBW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

1 Oct 2021

Employees

3.00

CEO

Gareth Sheridan

Description

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRBW Financial Timeline

Browse a chronological timeline of Nutriband Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 30 May 2025

EPS came in at -$0.12 falling short of the estimated -$0.12 by -4.03%, while revenue for the quarter reached $667.43K , beating expectations by +0.06%.

Earnings released on 31 Oct 2023

EPS came in at -$0.22 , while revenue for the quarter reached $427.84K .

Earnings released on 31 Jul 2023

EPS came in at -$0.11 , while revenue for the quarter reached $655.93K .

Earnings released on 30 Apr 2023

EPS came in at -$0.13 , while revenue for the quarter reached $476.93K .

Earnings released on 31 Jan 2023

EPS came in at -$0.20 , while revenue for the quarter reached $527.54K .

Earnings released on 31 Oct 2022

EPS came in at -$0.14 , while revenue for the quarter reached $618.00K .

Stock split effective on 15 Aug 2022

Shares were split 7 : 6 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Jul 2022

EPS came in at -$0.12 , while revenue for the quarter reached $456.15K .

Earnings released on 30 Apr 2022

EPS came in at -$0.09 , while revenue for the quarter reached $477.92K .

Earnings released on 31 Jan 2022

EPS came in at -$0.55 , while revenue for the quarter reached $491.89K .

Earnings released on 31 Oct 2021

EPS came in at -$0.23 , while revenue for the quarter reached $283.04K .

Earnings released on 31 Jul 2021

EPS came in at -$0.08 , while revenue for the quarter reached $213.74K .

Earnings released on 30 Apr 2021

EPS came in at -$0.05 , while revenue for the quarter reached $433.49K .

Earnings released on 31 Jan 2021

EPS came in at -$0.33 , while revenue for the quarter reached $348.09K .

Earnings released on 31 Oct 2020

EPS came in at -$0.01 , while revenue for the quarter reached $391.80K .

NTRBW Stock Performance

Access detailed NTRBW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run